Literature DB >> 25733064

Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements.

Jonathan Penm1, Betty Chaar, Rebekah Moles.   

Abstract

BACKGROUND: Clinical pharmacy services have been associated with decreased mortality rates, length of stay, medication errors, adverse drug reactions and total cost of care. Such services have recently been introduced to the Western Pacific Region (WPR), particularly in Asia. A survey to measure clinical pharmacy services that influence prescribing has been validated in the WPR and can be used to explore the implementation of such services.
OBJECTIVE: To explore the implementation of clinical pharmacy services that influence prescribing in the WPR and the barriers and facilitators involved in their implementation.
SETTING: Hospital pharmacies in the WPR.
METHOD: Hospital pharmacy directors in the WPR were emailed a link to the validated survey. Surveys were available in English, Japanese, Chinese, Vietnamese, Lao, Khmer, French and Mongolian. MAIN OUTCOME MEASURE: (1) Percentage of hospitals offering clinical pharmacy services. (2) Percentage of in-patients receiving a medication history, review or discharge counselling by a pharmacist.
RESULTS: In total, 726 responses were received from 31 countries and nations. Nearly all hospitals, 90.6 % (658/726), stated they provided clinical pharmacy services. On average 28 % of their clinical pharmacists attended medical rounds regularly. The median percentage of inpatients receiving a medication history and discharge counselling by a pharmacist was 40 and 30 % respectively. Higher internal facilitator factor scores significantly increased the likelihood of offering clinical services and having pharmacists attend medical rounds regularly. Internal facilitators included individual pharmacist traits and pharmacy departmental structure/resources. Higher environmental facilitator factor scores and having a higher percentage of pharmacists attend medical rounds regularly significantly increased the likelihood of inpatients receiving a medication history, a medication review and discharge counselling by a pharmacist. Environment facilitators included government support, patient and physician expectations.
CONCLUSION: A large proportion of hospitals in the WPR have implemented clinical pharmacy services. Although internal facilitators were shown to be important for initiating such services, the addition of environmental facilitators and ward round participation by pharmacists allowed clinical services to be integrated throughout the hospitals.

Entities:  

Mesh:

Year:  2015        PMID: 25733064     DOI: 10.1007/s11096-015-0084-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


  36 in total

1.  Evidence-based core clinical pharmacy services in United States hospitals in 2020: services and staffing.

Authors:  C A Bond; Cynthia L Raehl; Roland Patry
Journal:  Pharmacotherapy       Date:  2004-04       Impact factor: 4.705

2.  Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital.

Authors:  Jian Shen; Qingmin Sun; Xianmei Zhou; Yu Wei; Yongjian Qi; Jiping Zhu; Tingting Yan
Journal:  Int J Clin Pharm       Date:  2011-11-09

3.  Lessons learned from a pharmacy practice model change at an academic medical center.

Authors:  Scott J Knoer; John D Pastor; Pamela K Phelps
Journal:  Am J Health Syst Pharm       Date:  2010-11-01       Impact factor: 2.637

4.  Information needs of Chinese surgical patients on discharge:a comparison of patients' and nurses' perceptions.

Authors:  Hellene Y M Yiu; Wai-Tong Chien; May How-Lin Lui; Bai Qin
Journal:  J Adv Nurs       Date:  2010-12-03       Impact factor: 3.187

5.  Factors affecting the implementation of clinical pharmacy services in China.

Authors:  Jonathan Penm; Rebekah Moles; Holly Wang; Yan Li; Betty Chaar
Journal:  Qual Health Res       Date:  2014-02-21

6.  Opportunities and responsibilities in pharmaceutical care.

Authors:  C D Hepler; L M Strand
Journal:  Am J Hosp Pharm       Date:  1990-03

7.  Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.

Authors:  Jonathan Penm; Betty Chaar; Grenville Rose; Rebekah Moles
Journal:  Res Social Adm Pharm       Date:  2014-06-19

8.  ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2012.

Authors:  Craig A Pedersen; Philip J Schneider; Douglas J Scheckelhoff
Journal:  Am J Health Syst Pharm       Date:  2013-05-01       Impact factor: 2.637

9.  Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.

Authors:  H Y Wang; A L F Chan; M T Chen; C H Liao; Y F Tian
Journal:  Transplant Proc       Date:  2008-09       Impact factor: 1.066

Review 10.  Medication reconciliation during transitions of care as a patient safety strategy: a systematic review.

Authors:  Janice L Kwan; Lisha Lo; Margaret Sampson; Kaveh G Shojania
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

View more
  4 in total

1.  Use of the International Pharmaceutical Federation's Basel Statements to Assess and Advance Hospital Pharmacy Practice: A Scoping Review.

Authors:  Jonathan Penm; Betty Chaar; Rebekah J Moles
Journal:  Can J Hosp Pharm       Date:  2016-04-29

2.  Hospital clinical pharmacy services in Vietnam.

Authors:  Hieu T Trinh; Huong T L Nguyen; Van T T Pham; Hai L Ba; Phuong T X Dong; Thao T B Cao; Hanh T H Nguyen; Jo-Anne Brien
Journal:  Int J Clin Pharm       Date:  2018-04-07

3.  Perceived facilitators to change in hospital pharmacy practice in England.

Authors:  Asa Auta; Julia Maz; Barry Strickland-Hodge
Journal:  Int J Clin Pharm       Date:  2015-07-21

4.  Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study.

Authors:  Aya Ahmed Abousheishaa; Ahmad Hatim Sulaiman; Hasniza Zaman Huri; Siti Fatimah Binti Kamis; Hafizah Hamidi; Wei Chern Ang; Zainol Akbar Bin Zainal; Noorasyikin Shamsuddin; Ng Chong Guan
Journal:  BMC Health Serv Res       Date:  2022-03-09       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.